Latest news
BioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTContext drops bispecific T-cell engager on cost-cutting initiative - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:11:48 GMTDSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:11:48 GMTChina-ready by design: Leveraging NMPA’s new 30‑working day IND pathway - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 04:37:42 GMTModerna kicks off Phase I Ebola trial as Africa readies itself for research - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 18:00:37 GMTSummit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:27:59 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMT